Alcon AG | ALC - Current Liabilities


Alcon AG reported $3B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
AstraZeneca USD 32.57B 1.95B Mar/2026
Bayer EUR 33.46B 875M Mar/2026
Essilor EUR 12.15B 766M Dec/2025
Fresenius EUR 8.38B 1.18B Dec/2025
Fresenius Medical Care EUR 6.73B 484.42M Mar/2026
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
GRIFOLS EUR 2.12B 105M Mar/2026
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 9.35B 307M Mar/2026
Novartis USD 31.37B 4.1B Mar/2026
Philips EUR 7.43B 78M Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 30.01B 1.66B Mar/2026
Smith & Nephew USD 1.54B 236M Dec/2025
Sonova Holding CHF 1.5B 303M Jun/2025
UCB EUR 4.4B 470M Dec/2025